Free to read. Sign up to save tools and get alerts when they change. Plus 900+ more AI tool profiles.

Sign up free
5 min read·Updated July 2, 2026

Profluent

Profluent logoBy Profluent

Profluent trains large language models on the language of proteins to design new ones — including gene editors. It open-sourced OpenCRISPR-1, a functional AI-designed CRISPR gene editor, and built a large 'Protein Atlas' spanning billions of proteins.

Share

Listen to this overview

Free preview · first 0:30
0:00 / 0:30

Unlock audio and more

Audio streaming, downloadable PDFs and certificates come with Plus and Pro.

Learning Objectives

  • Understand how Profluent applies language models to protein and gene-editor design
  • Understand why OpenCRISPR-1 is a landmark demonstration
  • Evaluate frontier AI-for-biology results as early-stage science

What Is Profluent?

Profluent is an AI company that trains large language models on the language of proteins to design new ones — including, notably, gene editors. Just as a language model learns the patterns of human text, Profluent's models learn the patterns of protein sequences well enough to generate novel, functional ones. Its landmark demonstration was OpenCRISPR-1: a working CRISPR gene editor designed by AI rather than discovered in nature, which the company open-sourced. That result matters because it showed generative models can produce working molecular machines — not just plausible-looking sequences, but functional tools — pushing AI-for-biology past prediction into creation.

To train models of this ambition, Profluent has described building a large Protein Atlas spanning billions of proteins, and it has raised significant funding, with backers including Altimeter and Bezos Expeditions. Profluent sits at the frontier of the field, and its artifacts — like OpenCRISPR — are genuine scientific milestones worth understanding. The honest framing is equally important: these are early, research-stage results. Designing a functional gene editor in the lab is a powerful proof of concept, but the long work of turning designed editors and proteins into validated, safe therapies is still ahead. Profluent is best appreciated as evidence of what generative AI can now do in biology, with the clinical payoff a longer road.

💡Key Concept

Language models for proteins: Trained on the sequences of billions of proteins, Profluent's models generate new, functional ones — the same "learn the patterns, then generate" idea as text models, applied to biology.

📝Note

Why OpenCRISPR-1 is a milestone: It is a functional CRISPR gene editor designed by AI, not found in nature, and open-sourced — proof that generative models can create working molecular machines, not just predict structures.

🎯Tip

Visit Profluent: profluent.bio — research-stage AI protein and gene-editor design; OpenCRISPR-1 is open-sourced.

Pricing

Profluent is a research-and-platform company rather than a self-serve product; some artifacts (like OpenCRISPR-1) are open-sourced, while broader collaboration is arranged through partnerships.

Open ArtifactsFree / open-source
  • OpenCRISPR-1 gene editor
  • Research use
  • Community access
PartnershipCustom
  • Platform collaboration
  • Protein and editor design
  • Enterprise arrangements

Core Features

Protein Language Models

Trains large models on protein sequences to generate novel, functional proteins.

AI-Designed Gene Editors

Designs gene editors with AI, demonstrated by the functional, open-sourced OpenCRISPR-1.

Protein Atlas

Built a large dataset spanning billions of proteins to train ambitious generative models.

Open Contributions

Open-sourced landmark artifacts, contributing to the broader research community.

Strengths

  • Frontier capability — generative design of functional gene editors
  • A genuine milestone — OpenCRISPR-1, an AI-designed CRISPR editor
  • Open contributions — landmark artifacts released to the community
  • Large training foundation — a Protein Atlas of billions of proteins
  • Strong backing — well-capitalized frontier research

Limitations and Considerations

  • Research-stage results — proof of concept, not approved therapies
  • Long clinical road — designed editors face years of validation and safety work
  • Not a self-serve product — broader use is via partnership
  • Frontier uncertainty — capabilities are advancing and unproven at scale
  • Safety and ethics — designed gene editors raise serious considerations

Best Use Cases

Use CaseWhy Profluent FitsCaveat
AI-designed gene editorsDemonstrated with OpenCRISPR-1Research-stage, not therapies
Protein generationLanguage models design functional proteinsValidation still required
Learning frontier AI-for-biologyLandmark, open-sourced artifactsEarly, evolving field
Research collaborationPlatform and partnership accessNot self-serve

Key Takeaways

  • Profluent trains large language models on protein sequences to design new proteins and gene editors
  • It open-sourced OpenCRISPR-1, a functional AI-designed CRISPR gene editor — proof that generative models can create working molecular machines
  • It built a large Protein Atlas spanning billions of proteins and is backed by frontier investors
  • These are early, research-stage results: powerful proof of concept, with the long road to validated, safe therapies still ahead
  • It is best appreciated as frontier evidence of what generative AI can do in biology, and as a source of open, landmark artifacts

Keep track of the tools you’re evaluating

  • The AI Hub on a phone: a 12-day AI Skill Streak and an expanded Content updates alert listing the saved items that changed.
  • Recommended for you on a phone: nine personalised suggestions labelled Trending in AI news, On your saved list, and Popular.
  • My AI Tools on a phone: saved tools including GitHub Copilot and OpenAI Codex, each with an Updated badge.

Swipe for Recommended for you and My AI Tools

Your AI Hub — sample data.

Other tools in Pharma AI (12 of 85)

Show 7 more →
🧭Recommended for you

Optional detours — these connect to what you just read, and your next lesson will be waiting.